Claude Boccara
Career history of Claude Boccara
Former positions of Claude Boccara
| Companies | Position | Start | End |
|---|---|---|---|
Aquyre Biosciences, Inc.
 Aquyre Biosciences, Inc. Medical/Nursing ServicesHealth Services Aquyre Biosciences, Inc. is a biotech company that created Celtivity™, a rapid digital specimen adequacy assessment tool that can identify the presence of cancer cells and immune cells in a biopsy in just two minutes. The company is based in Weston, MA and was founded by Bertrand Le Conte de Poly, Claude Boccara. The assessment is presented as a cellular heatmap, making analysis and detection of cancer, granuloma, and immune cells such as lymphocytes relatively easier than traditional cancer diagnostic methods. Floyd Samuel Eberts has been the CEO of the company since 2023. | Chief Tech/Sci/R&D Officer | - | - |
| Founder | - | - |
Statistics
International
| United States | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectoral
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Aquyre Biosciences, Inc.
Aquyre Biosciences, Inc. Medical/Nursing ServicesHealth Services Aquyre Biosciences, Inc. is a biotech company that created Celtivity™, a rapid digital specimen adequacy assessment tool that can identify the presence of cancer cells and immune cells in a biopsy in just two minutes. The company is based in Weston, MA and was founded by Bertrand Le Conte de Poly, Claude Boccara. The assessment is presented as a cellular heatmap, making analysis and detection of cancer, granuloma, and immune cells such as lymphocytes relatively easier than traditional cancer diagnostic methods. Floyd Samuel Eberts has been the CEO of the company since 2023. | Health Services |
- Stock Market
- Insiders
- Claude Boccara
- Experience
